Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic.

JAMA oncology. 2021 Mar 01 [Epub]

Oncology patient care may be disrupted secondary to coronavirus disease 2019 (COVID-19) through delays in diagnostic investigations and surgical procedures, as well as delayed cancer diagnoses because of reduced cancer screening. This study assesses the number of patients undergoing cancer screening tests and of ensuing cancer diagnoses during the COVID-19 pandemic in the largest health care system in the northeastern United States, Massachusetts General Brigham.

Ziad Bakouny, Marco Paciotti, Andrew L Schmidt, Stuart R Lipsitz, Toni K Choueiri, Quoc-Dien Trinh

Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

, Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.

email news signup